(Q67671691)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1698423%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

title

Functional and phenotypic analyses of interleukin 2-activated tumor-infiltrating lymphocytes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1698423%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

1 reference

1 November 2022

author name string

H. Yamaue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1698423

1 November 2022

H. Tanimura

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1698423

1 November 2022

T. Tsunoda

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1698423

1 November 2022

M. Iwahashi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1698423

1 November 2022

M. Tani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1698423

1 November 2022

M. Tamai

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1698423

1 November 2022

M. Inoue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1698423

1 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1698423

1 November 2022

publication date

1 January 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1698423%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

16 September 2019

http://link.springer.com/content/pdf/10.1007/BF02173526.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF02173526/fulltext.html

1 November 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF02173526

1 November 2022

1 reference

Biotherapy (Dordrecht, Netherlands)

1 November 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1698423%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1698423%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1698423%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

page(s)

247-259

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1698423%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf02173526

16 September 2019

exact match

0 references

cites work

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1

1 reference

Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells

1 November 2022

2

1 reference

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

1 November 2022

5

1 reference

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 November 2022

7

1 reference

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 November 2022

10

1 reference

Tumor-derived interleukin-2-dependent lymphocytes in adoptive immunotherapy of lung cancer

1 November 2022

11

1 reference

Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study

1 November 2022

12

1 reference

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 November 2022

13

1 reference

Tumour-infiltrating lymphocytes and interleukin-2 in treatment of advanced cancer

1 November 2022

14

1 reference

Induction of activated natural killer cells from murine spleen cells primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432

1 November 2022

16

1 reference

Role of interleukin-2 and interferon-gamma in induction of activated natural killer cells from mice primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432

1 November 2022

17

1 reference

Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma

1 November 2022

18

1 reference

Phase I study of the adoptive immunotherapy of human cancer with lectin activated autologous mononuclear cells

1 November 2022

20

1 reference

Importance of MHC antigen expression on solid tumors in the in vitro interaction with autologous blood lymphocytes.

1 November 2022

21

1 reference

Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon

1 November 2022

22

1 reference

Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity

1 November 2022

24

1 reference

Properties of recombinant interleukin 2-cultured tumor-infiltrating lymphocytes in human lung cancer

1 November 2022

26

1 reference

Cytolytic antitumor effector cells in long-term cultures of human tumor-infiltrating lymphocytes in recombinant interleukin 2

1 November 2022

28

1 reference

Functional and phenotypic analysis of tumor-infiltrating lymphocytes isolated from human primary and metastatic liver tumors and cultured in recombinant interleukin-2

1 November 2022

29

1 reference

Clonal analysis of human tumor infiltrating lymphocytes reactive with autologous tumor cells: different target cell specificities of NK-like and cytotoxic T-cell clones

1 November 2022

30

1 reference

Tumor-specific T cells which form clusters with dendritic cells and tumor cells and deliver macrophage-activating factors.

1 November 2022

33

1 reference

Augmentation of human cytotoxic T lymphocytes against autologous tumor by a factor released from human monocytic leukemia cell line.

1 November 2022

34

1 reference